Cell No. : Cell Name
RCB2776 : P388
update : 2024/08/14
|
| Comment | Mouse cell line derived from lymphoid tumor. DBA/2 strain. TKG0326 (Deposited from Tohoku Univ.). |
| Comment from the depositor | |
| Terms and conditions | There is no restriction regarding use for basic researches. In relation to commercial use and use for patent filing, first of all please contact the RIKEN BRC. |
| Remarks | |
| Order Form |
Order Form(C-0005.pdf)
MTA(C-0007.pdf)
MTA(C-0007p.pdf)
|
|
Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, not-for-profit academic purpose (C-XXXX) and for-profit research purpose (C-XXXXp) , depending on the sort of user institutions and the purposes of use. Please use an appropriate MTA(to see). In relation to commercial use and use for patent filing, first of all Please contact RIKEN BRC (cellbank.brc@riken.jp).
|
|
|
Basic information
|
Depositor |
Fukuda, Hiroshi
|
| Year of deposit |
2008
|
| Original cell |
TKG0326
|
| Animal |
_mouse
< Mammals
|
| Strain name |
DBA/2
|
| Tissue |
lymphoid tumor
|
| Classification |
cancer
|
| History |
Cell Resource Center for Biomedical Research, Tohoku University（TKG0326）
|
|
Lifespan |
infinite
|
| Morphology |
lymphoblast-like
|
| Cellosaurus(Expasy) |
CVCL_7222
|
|
| |
deposit info |
lot info |
|
Medium |
Medium List |
|
Culture type |
|
Suspension cells
|
| Culture method |
|
浮遊細胞の培養に関する一般的な注意(Japanese)
|
| Culture medium |
|
RPMI1640 + 10% FBS
|
| Antibiotics |
|
Free
|
|
Passage method |
|
pipetting or 0.25% Trypsin
|
Culture information
|
Passage ratio |
|
1 : 8 split
|
| SC frequency |
|
Subculture : 2 times/week
|
| Temperature |
|
37
℃
|
| CO2 concentration |
|
5
%
|
| Freeze medium |
|
Medium + 10% DMSO
|
| Freezing method |
|
Slow freezing
|
| Mycoplasma/Acholeplasma |
|
(-)
|
| SSLP(mouse) |
|
OK
|
| Isozyme |
|
LD, NP
|
| Images |
deposit info | lot info |
|
|
|
| Reference information |
Reference |
5
|
| User's Publication |
2
|
| Reference |
|
5265
Mizel SB, Oppenheim JJ, Rosenstreich DL.
Characterization of lymphocyte-activating factor (LAF) produced by the macrophage cell line, P388D1. I. Enhancement of LAF production by activated T lymphocytes.
J Immunol
1978
120(5):1497-503
PubMed ID: 149171
|
|
716
Ralph P, Nakoinz I
Antibody-dependent killing of erythrocyte and tumor targets by macrophage-related cell lines: enhancement by PPD and LPS.
J Immunol
1977
119:950-54
PubMed ID: 894031
|
|
1141
Ralph P, Moore, M A, Nilsson K
Lysozyme synthesis by established human and murine histiocytic lymphoma cell lines.
J Exp Med
1976
143:1528-33
PubMed ID: 1083890
DOI: 10.1084/jem.143.6.1528
|
|
5264
EAGLE H.
METABOLIC CONTROLS IN CULTURED MAMMALIAN CELLS.
Science
1965
148(3666):42-51
PubMed ID: 14258726
DOI: 10.1126/science.148.3666.42
|
|
5266
ZWILLENBERG LO.
The dendritic cell system and mast cells in non-epidermal stratified squamous epithelium.
Nature
1958
181(4619):1343-4
PubMed ID: 13541472
DOI: 10.1038/1811343b0
|
Back
Top
CELL BANK Website